Cargando…
Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials
Escalation with overdose control (EWOC) is a Bayesian adaptive phase I clinical trial design that produces consistent sequences of doses while controlling the probability that patients are overdosed. However, this design does not take explicitly into account the time it takes for a patient to exhibi...
Autores principales: | Tighiouart, Mourad, Liu, Yuan, Rogatko, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963973/ https://www.ncbi.nlm.nih.gov/pubmed/24663812 http://dx.doi.org/10.1371/journal.pone.0093070 |
Ejemplares similares
-
Escalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose Finding
por: Rogatko, André, et al.
Publicado: (2015) -
The Integrated Web Portal for Escalation with Overdose Control (EWOC)
por: Wang, Haibin, et al.
Publicado: (2013) -
A Bayesian Adaptive Design for Combination of Three Drugs in Cancer Phase I Clinical Trials
por: Tighiouart, Mourad, et al.
Publicado: (2016) -
Toxicity‐dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials
por: Wheeler, Graham M., et al.
Publicado: (2017) -
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
por: Wheeler, Graham M.
Publicado: (2016)